Dr. Lubomir Sokol, MD, PhD
Claim this profileMoffitt Cancer Center
Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Lymphoid Leukemia
8 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Lubomir Sokol, MD, PhD is currently running
Pacritinib
for T-Cell Lymphoma
The main purpose of this study is to determine the effectiveness of the study drug pacritinib in people with relapsed or refractory lymphoproliferative disorders.
Recruiting1 award Phase 27 criteria
Phototherapy + Mogamulizumab
for Mycosis Fungoides
This trial tests a combination of light therapy and a drug called POTELIGEO for patients with early-stage skin cancer. The light therapy aims to improve skin conditions, while POTELIGEO helps the immune system target and destroy cancer cells.
Recruiting1 award Phase < 1
More about Lubomir Sokol, MD, PhD
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Lubomir Sokol, MD, PhD has experience with
- Mogamulizumab-Kpkc
- Phototherapy
- IPH4102
- Siltuximab
- Tabelecleucel
- Pacritinib
Breakdown of trials Lubomir Sokol, MD, PhD has run
T-Lymphoblastic Leukemia/Lymphoma
Lymphoid Leukemia
Mycosis Fungoides and Sezary Syndrome
Hematological Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lubomir Sokol, MD, PhD specialize in?
Lubomir Sokol, MD, PhD focuses on T-Lymphoblastic Leukemia/Lymphoma and Lymphoid Leukemia. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved BCR-ABL1 negative patients, or patients who are undergoing treatment.
Is Lubomir Sokol, MD, PhD currently recruiting for clinical trials?
Yes, Lubomir Sokol, MD, PhD is currently recruiting for 4 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Lubomir Sokol, MD, PhD has studied deeply?
Yes, Lubomir Sokol, MD, PhD has studied treatments such as Mogamulizumab-Kpkc, Phototherapy, IPH4102.
What is the best way to schedule an appointment with Lubomir Sokol, MD, PhD?
Apply for one of the trials that Lubomir Sokol, MD, PhD is conducting.
What is the office address of Lubomir Sokol, MD, PhD?
The office of Lubomir Sokol, MD, PhD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.